The Influence of Patent Foramen Ovale on the Clinical Features of Migraine without Aura: A Cross-Sectional Study
Qiuling Tong,Yu Yao,Yanhuo Xia,Zhibo Chen,Gangze Ji,Liuzhu Chen,Rujun Jin,Wanli Dong
DOI: https://doi.org/10.2147/IJGM.S423296
IF: 2.145
2023-08-22
International Journal of General Medicine
Abstract:Qiuling Tong, 1, 2 Yu Yao, 3 Yanhuo Xia, 4 Zhibo Chen, 2 Gangze Ji, 2 Liuzhu Chen, 2 Rujun Jin, 2 Wanli Dong 1 1 Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China; 2 Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China; 3 Department of Neurology, Ningbo First Hospital, Ningbo, People's Republic of China; 4 Department of Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China Correspondence: Wanli Dong, Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China, Tel +8651265223637, Fax +8657755579318, Email Objective: To investigate the influence of patent foramen ovale (PFO) on the clinical features of migraine without aura (MoA). Methods: We consecutively enrolled 390 MoA patients and compared the frequency of headache, episode duration, and the Visual Analogue Scale (VAS), Headache Impact Test 6 (HIT-6), and European Health Interview Survey-Quality of Life 8-item index (EUROHIS-QOL8) scores of patients with and without PFO, those with the mild right-to-left shunt (RLS) and moderate to large RLS, and those with permanent RLS and latent RLS using a nonparametric Mann–Whitney U -test. In addition, we analyzed the clinical features of migraine in 39 MoA patients before and after PFO closure treatment using the paired Wilcoxon test. Results: The prevalence of PFO in the 390 MoA patients was 44.4%. Patients with PFO had significantly higher frequency of headaches, VAS scores, HIT-6 scores, and incidence of white matter lesions than those without PFO (all p < 0.05). Patients with moderate to large RLS had significantly higher VAS scores than those with mild RLS ( p = 0.002). Additionally, 39 MoA patients underwent PFO closure, which remarkably decreased their frequency of headache, episode duration, VAS scores, and HIT-6 scores, and increased their EUROHIS-QOL8 scores. Conclusion: The migraine features in MoA patients could be influenced by PFO, especially in patients with moderate to large shunt, in whom PFO closure improved the symptoms. Keywords: migraine without aura, patent foramen ovale, clinical features, closure treatment Migraine is a ubiquitous, prevalent, chronic neuro-vascular disorder characterized by headache attacks. It severely affects people's health and quality of life and is a leading cause of disability worldwide in people younger than 50, especially in women. 1 There are over 1 billion migraine cases worldwide. 2,3 In China, a 1-year prevalence of migraine was up to 9% and was the cause of 331 years lived with disability (YLDs) per 100,000 people per year amounting to 5.5 million YLDs. 4 Moreover, inadequate awareness of migraine and clinically improper treatment, especially in underdeveloped regions, lead to chronic migraine, drug abuse and addiction, as well as medication overuse headache, 5,6 thereby augmenting public health burdens. Unfortunately, the pathophysiology of migraine remains incompletely elucidated. Migraine can be classified into two subtypes: migraine with aura (MA) and migraine without aura (MoA). Recent evidence suggests a correlation between the presence of patent foramen ovale (PFO) and MA. 7 PFO is present in 20% to 25% of the general population, 8,9 but the prevalence of PFO in patients with MA is more than twice as high as that in the general population. 8,10 More importantly, MA patients with moderate or large PFO have significantly higher frequencies of headaches, Headache Impact Test (HIT-6) scores, and migraine disability assessment scores (MIDAS) than those with mild PFO or without PFO. 11 The frequency and duration of headaches can effectively be reduced, and the quality of life can be improved after PFO closure treatment. 12 Overall, these findings suggest that the presence of PFO is an underlying factor in the pathogenesis of MA. Clinically, approximately 75% of migraineursareMoA. 13 However, the correlation between PFO and MoA receives insufficient attention. The clinical features of MoA patients with and without PFO have not been systematically analyzed. The efficacy of PFO closure for patients with MoA remains debatable to date. Here, to comprehensively investigate the influence of PFO on MoA, we consecutively enrolled 390 MoA patients and analyzed the migraine characteristics under different statuses of PFO. In addition, we analyzed the efficacy of PFO closure in 39 patient -Abstract Truncated-
medicine, general & internal